Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 4
1952 2
1953 1
1954 6
1955 12
1956 6
1957 3
1958 23
1959 13
1960 9
1961 14
1962 16
1963 24
1964 18
1965 28
1966 33
1967 32
1968 35
1969 42
1970 43
1971 61
1972 50
1973 49
1974 48
1975 48
1976 48
1977 71
1978 59
1979 77
1980 75
1981 67
1982 89
1983 78
1984 81
1985 78
1986 105
1987 110
1988 123
1989 134
1990 121
1991 121
1992 142
1993 133
1994 124
1995 118
1996 131
1997 171
1998 159
1999 173
2000 227
2001 238
2002 213
2003 257
2004 270
2005 294
2006 294
2007 313
2008 319
2009 371
2010 383
2011 439
2012 440
2013 459
2014 422
2015 455
2016 451
2017 450
2018 469
2019 454
2020 327
Text availability
Article attribute
Article type
Publication date

Search Results

9,882 results
Results by year
Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I; DESTINY-Breast01 Investigators. Modi S, et al. Among authors: ito y. N Engl J Med. 2020 Feb 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11. N Engl J Med. 2020. PMID: 31825192 Clinical Trial.
Wwp2 maintains cartilage homeostasis through regulation of Adamts5.
Mokuda S, Nakamichi R, Matsuzaki T, Ito Y, Sato T, Miyata K, Inui M, Olmer M, Sugiyama E, Lotz M, Asahara H. Mokuda S, et al. Among authors: ito y. Nat Commun. 2019 Jun 3;10(1):2429. doi: 10.1038/s41467-019-10177-1. Nat Commun. 2019. PMID: 31160553 Free PMC article.
Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).
Iwata H, Inoue K, Kaneko K, Ito Y, Tsugawa K, Hasegawa A, Nakagawa S, Kuratomi H, Tamura K. Iwata H, et al. Among authors: ito y. Jpn J Clin Oncol. 2019 Dec 27;49(12):1083-1091. doi: 10.1093/jjco/hyz135. Jpn J Clin Oncol. 2019. PMID: 31612909 Free PMC article. Clinical Trial.
Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticity.
Matsumura Y, Ito Y, Mezawa Y, Sulidan K, Daigo Y, Hiraga T, Mogushi K, Wali N, Suzuki H, Itoh T, Miyagi Y, Yokose T, Shimizu S, Takano A, Terao Y, Saeki H, Ozawa M, Abe M, Takeda S, Okumura K, Habu S, Hino O, Takeda K, Hamada M, Orimo A. Matsumura Y, et al. Among authors: ito y. Life Sci Alliance. 2019 Jul 22;2(4):e201900425. doi: 10.26508/lsa.201900425. Print 2019 Aug. Life Sci Alliance. 2019. PMID: 31331982 Free PMC article.
Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
Kinguchi S, Wakui H, Ito Y, Kondo Y, Azushima K, Osada U, Yamakawa T, Iwamoto T, Yutoh J, Misumi T, Aoki K, Yasuda G, Yoshii T, Yamada T, Ono S, Shibasaki-Kurita T, Hosokawa S, Orime K, Hanaoka M, Sasaki H, Inazumi K, Yamada T, Kobayashi R, Ohki K, Haruhara K, Kobayashi Y, Yamanaka T, Terauchi Y, Tamura K. Kinguchi S, et al. Among authors: ito y. Cardiovasc Diabetol. 2019 Aug 27;18(1):110. doi: 10.1186/s12933-019-0912-3. Cardiovasc Diabetol. 2019. PMID: 31455298 Free PMC article. Clinical Trial.
New Japanese Society of Dialysis Therapy Guidelines for Peritoneal Dialysis.
Ito Y, Tawada M, Yuasa H, Ryuzaki M. Ito Y, et al. Contrib Nephrol. 2019;198:52-61. doi: 10.1159/000496523. Epub 2019 Apr 16. Contrib Nephrol. 2019. PMID: 30991403
Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
Yamada K, Ito Y. Yamada K, et al. Among authors: ito y. Chembiochem. 2019 Nov 4;20(21):2729-2737. doi: 10.1002/cbic.201900178. Epub 2019 Jul 17. Chembiochem. 2019. PMID: 30973187 Review.
RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point.
Lee JW, Kim DM, Jang JW, Park TG, Song SH, Lee YS, Chi XZ, Park IY, Hyun JW, Ito Y, Bae SC. Lee JW, et al. Among authors: ito y. Nat Commun. 2019 Apr 23;10(1):1897. doi: 10.1038/s41467-019-09810-w. Nat Commun. 2019. PMID: 31015486 Free PMC article.
The Volume of Pediatric Blood Culture.
Kusama Y, Shime N, Ito K, Ito Y, Kasai M. Kusama Y, et al. Among authors: ito y. Pediatr Infect Dis J. 2019 Dec;38(12):e340-e341. doi: 10.1097/INF.0000000000002466. Pediatr Infect Dis J. 2019. PMID: 31738348 No abstract available.
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
Iozumi K, Abe M, Ito Y, Uesugi T, Onoduka T, Kato I, Kato F, Kodama K, Takahashi H, Takeda O, Tomizawa K, Nomiyama T, Fujii M, Mayama J, Muramoto F, Yasuda H, Yamanaka K, Sato T, Oh-I T, Kasai H, Tsuboi R, Hattori N, Maruyama R, Omi T, Shimoyama H, Sei Y, Nakasu I, Nishimoto S, Hata Y, Mochizuki T, Fukuzawa M, Seishima M, Sugiura K, Katayama I, Yamamoto O, Shindo M, Kiryu H, Kusuhara M, Takenaka M, Watanabe S. Iozumi K, et al. Among authors: ito y. J Dermatol. 2019 Aug;46(8):641-651. doi: 10.1111/1346-8138.14935. Epub 2019 Jun 17. J Dermatol. 2019. PMID: 31206779 Free PMC article. Clinical Trial.
9,882 results
Jump to page
Feedback